Document is current
Any future updates will be listed below
-
Authors
Lowe, Michael
Murray, Lesley
Tyagi, Alok
Gorrie, George
Miller, Sarah
Dani, Krishna
,
- License Information
-
More Information
Article History
Received: 30 April 2022
Accepted: 13 July 2022
First Online: 22 July 2022
Declarations
:
: Not applicable.
: Not applicable.
: ML reports no disclosures. LM has received speaker honoraria for training and educational events, provided consultancy services for advisory boards and received conference sponsorship from Arvelle Therapeutics UK, Biogen Idec, CSL Behring, GW Pharma, Merck and Teva UK. AT has received grants for attending meetings, has attended advisory boards and participated in satellite symposia organised by Novartis, Teva UK, Lilly and Lundbeck. He was a principle investigator in a randomised clinical trial of erenumab funded by Amgen. GG was a sub-investigator in a randomised clinical trial of erenumab funded by Amgen. SM has received speaker honoraria from Teva UK. KD has received funding from Novartis and Allergan for attendance at educational meetings, from Allergan for chairing an education meeting, and participated in a Chronic Migraine Educational Steering committee sponsored by Allergan.
